Background {#Sec1}
==========

In developed countries cancer, cardiovascular diseases and respiratory diseases are the main causes of death \[[@CR1], [@CR2]\]. Each year, in the Netherlands, about 140,000 persons die and two third of them die non-acutely of one of these three diseases (<http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=71594ned>). Particularly in advanced stages of these diseases, symptom burden is high \[[@CR3]--[@CR5]\].

In order to improve the care for patients with incurable, life-limiting diseases, the WHO stated in 2002 that palliative care should be initiated in an early phase of the disease. A timely start facilitates anticipatory care planning in order to meet patient wishes and needs, to relieve symptoms and to prevent future symptoms and problems. Regardless of the WHO recommendation, palliative care is often restricted to a reactive approach and to the relief of physical symptoms in the terminal phase, often resulting in emergency visits by the general practitioner (GP) \[[@CR6]\], unplanned transfers \[[@CR7], [@CR8]\] and hospital admissions \[[@CR9], [@CR10]\]. Consequently, too many patients die in another place than preferred, often with ineffective, costly and unwanted interventions \[[@CR11]--[@CR13]\].

Anticipatory care planning by earlier identification of the needs of patients in an advanced stage of their disease appeared to improve the quality of their remaining life, to decrease the number of aggressive futile interventions and depressed mood and even to prolong life in patients with advanced cancer \[[@CR14]--[@CR16]\].

Identification of patients who can benefit from anticipatory palliative care alongside or instead of disease-oriented therapies, is challenging particularly in patients with chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF), due to the fact that the course of these disease trajectories is difficult to predict \[[@CR17]--[@CR21]\]. In addition, these patients often don't realise that they have a limited life expectancy \[[@CR22]\]. In order to facilitate the identification of patients at risk of deterioration or dying, and thus for anticipatory palliative care, several sets of indicators have been developed, such as the Supportive and Palliative Care Indicators Tool (SPICT) in Scotland, the Prognostic Indicator Guide (PIG) in England, Neccesidades palliativas (NECPAL) in Spain and the Radboud indicators for Palliative Care needs (RADPAC) in the Netherlands \[[@CR23]\]. These tools contain general or disease-specific indicators of decline. Examples of these indicators are repeated hospital admissions, weight loss, decrease in functional status, and the surprise question (*Would you be surprised if this patient were to die in the next twelve months?*).

In the Netherlands patients are registered with a doctor's general practice, as part of their health care insurance. This structures a relation with a personal GP, who provides care for the large majority of their health problems presented and is the gatekeeper to specialist and hospital care. Through this structure, GPs have an overview and often intimate knowledge of the patient and his/her health conditions and social environment. This primary care-based structure plays an important role in coordinating early palliative care. GPs consider palliative care an attractive and essential part of their task, but experience difficulties with timely initiation and their coordinating role in palliative care \[[@CR24], [@CR25]\].

For those reasons, we developed a training for GPs in using a previously developed set of identification indicators, the RADPAC \[[@CR26]\], in planning and providing structured anticipatory palliative care and in communicating end-of-life issues with the patient. We expected that this training would improve the care for palliative patients with cancer, COPD or CHF in the form of less contacts with the out-of-hours hours primary care cooperative, a decreased number of hospitalizations in the last three months of life, an increased number of contacts with their own GP in the last month of life and an increased number of patients that would die at home. We tested this in a cluster randomised controlled trial (RCT).

Methods {#Sec2}
=======

Design {#Sec3}
------

A clustered, two-armed RCT was performed, with the GP as cluster. The study ran from February 2009 until February 2011.

Ethical considerations {#Sec4}
----------------------

The study was approved by the research ethics committee of the Radboud University Nijmegen Medical Center in accordance with the Medical Research Involving Human Subjects Acts (WMO). It also conforms to the Helsinki Declaration.

Participants {#Sec5}
------------

All GP practices in two regions of the comprehensive cancer centre of the Netherlands were invited by mail to participate. GPs were excluded if they were a consultant in a palliative care team. Participating GPs were stratified for working hours (part-time or full-time) and for degree of urbanization of their general practice (urban or rural) and they were randomly assigned to the intervention or control group by an independent statistician. To prevent contamination, GPs working together in the same practice were allocated to the same study group. Borland C software was used to randomly allocate GPs, as sequentially numbered containers, to the strata of one of both groups.

Intervention {#Sec6}
------------

The intervention, described in detail elsewhere \[[@CR27]\], consisted of three consecutive parts: 1. a five hour group training in early identification of those patients in their practice that can be considered as being palliative patients, by means of the RADPAC \[[@CR26]\], and in proactive care planning, 2. an individual coaching session by phone with a physician specialized in palliative care, per identified palliative patient for the GP and 3. two additional peer group sessions with the GPs in the intervention group a few months after start of the intervention, with a focus on patient -- GP communication regarding the initiation of a palliative care trajectory. The GPs in the intervention group were invited to use the RADPAC indicators to screen the medical records of all persons in their practice to identify those patients with CHF, COPD or cancer who potentially could benefit from a palliative care approach. They were also asked to use this screening instrument whenever new data of any patient with one of these three diseases became available, in order to timely identify the change from a curative to a palliative trajectory. They were asked to consider and start structured anticipatory palliative care for every identified patient. The GPs discussed palliative care and the study with the patient, and provided him or her a brochure with information about palliative care, the content of the study and what participation would imply for the patient.

GPs in the control group were asked to provide care as usual. Although this usual care differs per GP, they all have easy access to a large number of palliative care standards ([www.Oncoline.nl](http://www.oncoline.nl/#_blank%23www.Oncoline.nl)), and each physician and nurse in the Netherlands can consult a specialist in palliative care 24/7 by phone \[[@CR28]\].

Data collection {#Sec7}
---------------

At baseline, demographics and practice characteristics of each participating GP were collected, as well as their interest in palliative care (on a numeric rating scale (NRS) from 0, not interested at all to 10, extremely interested) and their confidence in providing palliative care by themselves (NRS from 0, not confident at all to 10, extremely confident).

If the patient was interested to participate, the GP asked him or her to sign an informed consent form, which was faxed to the researcher, together with a questionnaire with characteristics of the patient. The consulted palliative care specialists were asked to register each coaching session that they had with the GPs.

After 12 months, GPs that had not yet identified any patients for proactive palliative care were phoned by the research assistant and were asked in the form of an open question what the reason for non-inclusion was.

One year after start of the study, a questionnaire was sent to each GP in as well the intervention as the control group. They were asked to provide anonymous data, collected from the medical records of all patients that died in the past 12 months. This data included whether or not the patient died a sudden death, cause of death, age, gender, number and type of contacts with the GP out-of-hours service (by phone, consultation at the service, home visit) in the last three months before death, number and type of contacts with their own GP in the last month before death (phone calls and home visits during office hours and phone calls and home visits during out of office hours), place of death and number of hospital admissions in the last three months of life. Regarding out-of-hours contacts and contact with their own GP we chose a limited period of respectively one and three months before death, as we considered this a feasible period to check the electronic medical record, and as such contacts are most frequent near the end of life.

Statistical analyses {#Sec8}
--------------------

The primary outcome measure was the number of contacts with the out-of-hours GP cooperative. We estimated that with 96 patients in each group, the study would have an 80 % power to detect a significance between the intervention and control group, which would be a 20 % reduction of out-of-hours contacts \[[@CR27]\].

Statistical analysis was performed with the use of SPSS software, version 20.0 and with SAS software, version 9.2. Descriptive statistics were used to calculate frequencies, means, and standard deviations of the study variables. Differences between GPs in baseline characteristics were assessed with the use of chi-square tests for categorical variables and Student's t-tests for continuous variables. To study differences, between deceased patients in both study groups, mixed effects models were used (SAS GLIMMIX), with the GP as a cluster. In this model, the type of disease the patient died of, the age of the GP, working hours, interest in palliative care, and estimation of the GP's own capacity were included in the model as possible confounders.

It appeared that only a portion of the deceased patients had actually been identified as in need of palliative care in the intervention group. Therefore we performed a post-hoc analysis. We also used the same model to study differences between those patients that had been identified as in need of palliative care by GPs in the intervention group, and all other deceased patients (in as well the control and the intervention group).

Results {#Sec9}
=======

Within a period of one month, 159 GPs positively responded to the invitation to participate (Fig. [1](#Fig1){ref-type="fig"}). After stratification, they were randomly assigned to the intervention (*n* = 80) or control group (*n* = 79). For various reasons, 22 GPs in the intervention group were not able to join the training course. A majority of these 22 GPs worked fulltime (60 %), had slightly less years of experience (20 % had 0--5 years), worked in a group or health center (50 %), and had a larger patient list (2684 patients). Yet, the estimated number of palliative patients in this group was lower (only 23.8 % estimated to have 5 or more palliative patients per year).Fig. 1Enrolment, follow up and analyses of GPs

Additionally, one GP from the intervention group and 2 GPs from the control group were excluded because they were already trained in specialised palliative care. For those reasons, 57 GPs received the RADPAC indicators and the training and 77 GPs were considered as control group (Fig. [1](#Fig1){ref-type="fig"}).

Of the 57 GPs that received the initial training, 28 GPs also followed the two additional peer group sessions.

The characteristics of trained GPs in the intervention and GPs in the control arm did not differ in mean age, gender, working hours, years of experience and use of a consultation service for palliative care. Also their interest in palliative care and the estimation of their own capacity to provide palliative care was the same in both groups (Table [1](#Tab1){ref-type="table"}). Fewer GPs in the intervention arm worked in single-handed practices. The degree of urbanisation of their practice was about the same in both groups, as well as the size of their patient list.Table 1GP and practice characteristicsInterventionControl(*n* = 57)(*n* = 77)Age mean (sd)48.54 (7.92)47.85 (8.16)Male gender n (%)36 (63.2)45 (58.4)Working hours n (%)Fulltime29 (50.9)41 (53.9)Parttime28 (49.1)35 (46.1)Years experience n (%)0--56 (10.7)10 (13.2)6--1011 (19.6)10 (13.2)≥1039 (69.6)56 (73.7)Interest in pall care^1^ mean (sd)8.21 (0.92)8.09 (1.18)Estimation of own capacity to provide pall care^2^ mean (sd)6.80 (0.92)6.85 (0.93)Practice type n (%)Single-handed9 (15.8)19 (24.7)Dual28 (49.1)26 (33.8)Group or health center20 (35.1)32 (41.6)Urbanisation degree n (%)High21 (36.8)26 (33.8)Moderate9 (15.8)19 (24.7)Low18 (31.6)23 (29.9)No9 (15.8)9 (11.7)Patient list mean (sd)1710 (412)1730 (417)Estimated number of palliative patients/year n (%)≤24 (7.1)7 (9.2)3--529 (51.8)43 (56.6)5--920 (35.7)23 (30.3)≥103 (5.4)3 (3.9)^1^Interest in palliative care: numeric rating scale (NRS) from 0 (no interest at all) to 10 (extremely interested)^2^Estimation of own capability: NRS from 0 (not capable at all) to 10 (extremely capable)

Of the 57 trained GPs in the intervention group, 28 GPs identified 52 patients (0.91 per GP; 0--4) and in 33 cases the GP had an individual coaching session with the specialist in palliative care by phone (0.58 per GP).

Twenty-nine GPs in the intervention group did not identify any suitable patient for proactive palliative care. Reasons for not having included any patients, as mentioned by the GPs during a phone call, were having had no patients that met the RADPAC indicators, difficulty initiating an appropriate discussion on proactive palliative care, or rapid deterioration or death immediately after having communicated palliative care with the patient.

Seventy-seven of the 134 GPs (57 %) returned the questionnaire with retrospective data of deceased patients: 38 of the 57 GPs (67 %) in the intervention group and 39 of the 77 GPs (48 %) in the control group. In total, data from 622 deceased patients was retrieved, of which 487 (78 %) died of cancer, COPD or CHF or a combination of these.

In the intervention (I) and control (C) group comparable numbers of patients per GP died of cancer, CHF or COPD within the past 12 months (I:5.7; C: 6.9). Mean age of the patients (I: 73; C: 74) was the same as well as the gender distribution (male patients: I: 53 %; C: 56 %).

The primary diagnosis of the deceased patients was cancer (I 70 %; C: 66 %), followed by CHF (I: 15 %; C: 19 %), COPD (I: 12 %; C: 7 %) or a combination of these diseases (I:3 %; C: 8 %) (Table [2](#Tab2){ref-type="table"}).Table 2Patients who died of cancer, COPD or coronary heart failure (CHF) during the intervention periodInterventionControl(*N* = 216)(*N* = 271)Age in years (mean (sd)73.0 (14.7)74.0 (13.1)Male sex n (%)106/202 (53 %)144/258 (56 %)Primary diagnosis n (%) Cancer152/216 (70 %)178/271 (66 %) CHF32/216 (15 %)52/271 (19 %) COPD26/216 (12 %)20/271 (7 %) Combination of cancer, COPD, CHF6/216 (3 %)21/271 (8 %)Contact(s) with out-of-hours GP service last 3 months n (%)114/209 (55 %)157/268 (59 %)By phone0.79 (2.6)0.80 (1.5)Consultation at service0.06 (0.3)0.09 (0.5)Home visits0.85 (1.6)1.14 (2.2)*Total*1.70 (3.3)2.03 (2.9)Contact(s) with own GP last month n (%)188/212 (89 %)250/268 (93 %)By phone office hours2.33 (2.9)2.71 (3.0)Home visits office hours5.59 (5.1)4.42 (3.6)By phone out of office hours0.19 (0.7)0.10 (0.5)Home visits out of office hours0.46 (1.1)0.38 (1.1)*Total*8.58 (7.5)7.62 (6.0)Location of death n (%)Home103/210 (49 %)124/267 (46 %)Hospital67/210 (32 %)78/267 (29 %)Nursing home13/210 (6 %)16/267 (6 %)Care home12/210 (6 %)21/267 (8 %)Hospice14/210 (7 %)25/267 (9 %)Other location1/210 (1 %)3/267 (1 %)Hospital admission(s) last 3 months n (%)116/210 (55 %)159/255 (62 %)Hospital admissions last 3 months mean (sd)0.82 (0.9)0.89 (0.9)Data are mean (sd) or n/N (%). Some percentages do not sum to 100 % because of rounding

In the mixed model analyses, we found intra cluster coefficients (ICCs) from 0.04 (dying at home) to 0.14 (out-of-hours contacts). We found no differences between the intervention and control group in the number of contacts with the GP out-of-hours cooperative in that last three months, nor in the number of contacts a patient had with their own GP in the last month, hospitalisations in the last three months, dying at home or dying in the hospital (Table [3](#Tab3){ref-type="table"}).Table 3Mixed effects model estimating the effect of interventionB^1^95 % CIp*Number of contacts with out-of-hours GP service last 3 months*Intervention group0.4828−0.733 − 1.6980.4307Cause of death^2^0.4599 CHF−0.1016−0.806 -- 0.603 COPD−0.4729−1.403 -- 0.457 Combination0.6775−0.515 -- 1.870GP works fulltime1.0229−0.181 -- 2.2270.0946Age of GP^3^−0.0792−0.155 − −0.0030.0418Interest in palliative care^3^−0.8286−1.461 − −0.1960.0110Self-efficacy regarding PC^3^0.3191−0.384 − 1.0220.3679*Number of contacts with own GP last month*Intervention group0.7155−0.935 − 2.3660.3901Cause of death^2^\<.0001 CHF−3.8582−5.434 − −2.283 COPD−5.0800−7.173 − −2.987 Combination−4.1761−6.883 − −1.470GP works fulltime−1.1778−2.803 -- 0.4470.1526Age of GP^3^−0.0035−0.108 -- 0.1010.9474Interest in palliative care^3^0.3770−0.477 -- 1.2310.3813Self-efficacy regarding PC^3^−0.6855−1.649 -- 0.2780.1602Intervention groupOR^4^95 % CIp*Hospitalisation(s) last three months yes/no*Intervention group0.7970.464 -- 1.3720.4078Cause of death^2^0.0132 CHF0.7290.423 -- 1.256 COPD2.3001.056 -- 5.011 Combination3.1651.092 -- 9.172GP works fulltime0.9170.539 -- 1.5610.7467Age of GP^3^1.0170.983 -- 1.0530.3207Interest in palliative care^3^0.8020.606 -- 1.0610.1202Self-efficacy regarding PC^3^1.2270.895 -- 1.6820.1993*Dying at home yes/no*Intervention group1.1300.646 − 1.9760.6655Cause of death^2^\<.0001 CHF0.3930.227 -- 0.682 COPD0.1740.075 -- 0.405 Combination0.1670.059 -- 0.472GP works fulltime1.3590.784 -- 2.3560.2697Age of GP^3^0.9950.960 -- 1.0300.7644Interest in palliative care^3^1.1090.833 -- 1.4770.4721Self-efficacy regarding PC^3^0.7760.558 -- 1.0790.1295*Dying in hospital yes/no*Intervention group1.0950.684 -- 1.7540.7012Cause of death^2^0.0009 CHF1.5010.862 -- 2.611 COPD3.6921.870 -- 7.292 Combination2.6171.102 -- 6.217GP works fulltime0.8630.541 -- 1.3760.5303Age of GP^3^0.9910.962 -- 1.0210.5468Interest in palliative care^3^1.0210.800 -- 1.3030.8654Self-efficacy regarding PC^3^1.2540.936 -- 1.6800.12711) B = difference of means2) cause of death (cancer, CHF, COPD or combination of those; cancer is reference group), age of GP, working hours, interest in palliative care, and estimation of own capacity were included in the model as possible confounders3) Effects of continuous variables are assessed as one unit offsets from the mean4) OR = odds ratio

There was a relation found between the cause of death and the number of contacts that the patient had with their own GP within the last month of life (*p* \< 0.0001) (Table 3). For patients with cancer, the number of contacts in the last month of life with their own GP was higher than for patients with CHF, COPD or a combination of these diseases. Cause of death was also related to having had at least one hospitalization in the last three months of life (p 0.0132). Patients with COPD were more often hospitalized, as well as those patients with a combination of these diseases, while patients with CHF had smaller odds to be hospitalized. Finally, the cause of death was related to dying at home (*p* \< 0.0001), and to dying in the hospital (p 0.0009). Patients with cancer died more often at home and less often in the hospital than patients with one of the other causes of death.

Post-hoc analysis: identified patients versus all other patients {#Sec10}
----------------------------------------------------------------

Of the 52 patients that had been identified as in need of palliative care, there were 50 with available data; two patients had moved and it was not possible to follow up on their status. One patient (with COPD) was still alive at the moment that the retrospective data was collected. Data of the remaining 49 deceased patients was compared to data of all other patients from GPs in the intervention as well as the control group (*n* = 437) that died of cancer, COPD or CHF or a combination of these.

Table [4](#Tab4){ref-type="table"} shows that the identified patients were younger than the other patients (64.8 versus 74.6 years). Also their primary diagnosis differed; the identified patients were more likely to have cancer (86 versus 66 %), and less often CHF (4 % versus 19 %).Table 4Difference between those patients that were identified as in need of palliative care and all othersDeceased patients who were identified as in need of palliative careDeceased patients without those identified(*N* = 49)(*N* = 428)Age mean (sd)64.8 (12.1)74.6 (13.7)Male sex n (%)30/49 (61 %)219/409 (54 %)Primary diagnosis n (%)Cancer42/49 (86 %)287/436 (66 %)CHF2/49 (4 %)82/436 (19 %)COPD4/49 (8 %)41/436 (9 %)Combination of cancer, COPD, CHF1/49 (2 %)26/436 (6 %)Contact(s) with out-of-hours GP service last 3 months n (%)24/47 (51 %)247/430 (57 %)By phone1.26 (4.9)0.74 (1.4)Consultation at service0.04 (0.2)0.08 (0.4)Home visits0.64 (1.1)1.05 (2.1)*Total1.94 (5.2)1.88 (2.8)*Contact(s) with own GP last month n (%)45/49 (92 %)393/431 (91 %)By phone office hours means3.14 (3.8)2.47 (2.8)Home visits office hours means8.27 (6.7)4.55 (3.8)By phone out of office hours0.46 (1.2)0.11 (0.5)Home visits out of office hours1.02 (1.7)0.35 (1.0)*Total mean13.00 (9.8)7.48 (6.0)*Location of death n (%)Home33/49 (67 %)194/428 (45 %)Hospital7/49 (14 %)138/428 (32 %)Nursing home5/49 (10 %)24/428 (6 %)Care home0/49 (0 %)33/428 (8 %)Hospice4/49 (8 %)35/428 (8 %)Other location0/49 (0 %)4/428 (1 %)Hospital admission(s) last 3 months n (%)20/48 (42 %)255/417 (61 %)Hospital admissions last 3 months mean (sd)0.60 (1.0)0.89 (0.9)Data are mean (sd) or n/N (%). Some percentages do not sum to 100 % because of rounding

The number of contacts in the last three months of life with the out-of-hours GP service was the same in both groups. Yet, the identified patients had more contacts with their own GP in the last month of life (13.00 versus 7.48). Also the location of death differed: the identified patients died at home more often (67 versus 45 %) and less often in the hospital (14 versus 32 %) (Table [4](#Tab4){ref-type="table"}).

Finally, a smaller percentage of the identified patients had had at least one hospitalisation in the last three months of their life as compared to the other patients (42 versus 61). The mean number of hospital admissions of identified patients was also lower (0.60 versus 0.89).

We found no differences in number of contacts with the out-of-hours GP cooperative in the clustered model, controlled for GP clusters, cause of death (cancer, CHF, COPD or a combination of these), the GP working part-time or fulltime, age of the GP, interest in palliative care and self-efficacy regarding providing palliative care (Table [5](#Tab5){ref-type="table"}). However, there was a difference in the number of contacts that identified patients had with their own GP in the last month before death (p 0.0006). They were less often hospitalized in the last three months of life (p 0.0437), and died less often in the hospital (p 0.0449). Although they also died more often at home, this difference was not statistically significant (p 0.0572).Table 5Mixed effects model estimating the effect of being identified as in need of palliative careB^1^95 % CIp*Number of contacts with out-of-hours GP cooperative last 3 months*Identified patients−0.0832−1.156 -- 0.9890.8695Cause of death^2^0.4831CHF−0.1240−1.833 -- 0.585COPD−0.470−1.404 -- 0.464Combination0.6421−0.553 -- 1.837GP works fulltime1.0132−0.164 -- 2.1900.0904Age of GP^3^−0.0776−0.152 − −0.0030.0410Interest in palliative care^3^−0.8049−1.422 − −0.1880.0113Self-efficacy regarding PC^3^0.3545−0.328 -- 1.0370.3033*Number of contacts with own GP last month*Identified patients4.52182.336 -- 6.7070.0006Cause of death^2^\<0.0001CHF−3.5003−5.054 − −1.947COPD−4.8675−6.920 − −2.815Combination−3.9826−6.633 − −1.332GP works fulltime−1.3109−2.865 -- 0.2430.0970Age of GP^3^−0.0008−1.101 -- 0.0990.9876Interest in palliative care^3^0.4259−0.387 -- 1.2380.2993Self-efficacy regarding PC^3^−0.8122−1.730 -- 0.1050.0817Intervention groupOR^4^95 % CIp*Hospitalisation(s) last three months yes/no*Identified patients0.4850.215 -- 0.9750.0437Cause of death^2^0.0117CHF0.6820.395 -- 1.179COPD2.2271.017 -- 4.879Combination3.1051.074 -- 8.973GP works fulltime0.9390.557 -- 1.5830.8094Age of GP^3^1.0180.984 -- 1.0540.2937Interest in palliative care^3^0.7920.603 -- 1.0410.0935Self-efficacy regarding PC^3^1.2410.912 -- 1.6880.1663*Dying at home yes/no*Intervention group2.1260.974 -- 4.6430.0572Cause of death^2^\<0.0001CHF0.4180.240 -- 0.726COPD0.1770.076 -- 0.414Combination0.1720.061 -- 0.485GP works fulltime1.3210.762 -- 2.2910.3166Age of GP^3^0.9950.960 -- 1.0300.7629Interest in palliative care^3^1.1160.839 -- 1.4830.4465Self-efficacy regarding PC^3^0.7610.549 -- 1.0550.1000*Dying in hospital yes/no*Identified patients0.3800.148 -- 0.9750.0449Cause of death^2^0.0011CHF1.3610.781 -- 2.371COPD3.8671.928 -- 7.757Combination2.4231.025 -- 5.726GP works fulltime0.8840.554 -- 1.4090.5991Age of GP^3^0.9890.960 -- 1.0190.4619Interest in palliative care^3^1.0310.809 -- 1.3130.8025Self-efficacy regarding PC^3^1.3090.980 -- 1.7480.06781) B = difference of means2) cause of death (cancer, CHF, COPD or combination of those; cancer is reference group), age of GP, working hours, interest in palliative care, and estimation of own capacity were included in the model as possible confounders3) Effects of continuous variables are assessed as one unit offsets from the mean4) OR = odds ratio

Discussion {#Sec11}
==========

This study reports the results of an RCT on the effects of training GPs in early identification of patients that could profit from palliative care and in structured anticipatory palliative care planning. There was no difference found in the primary outcome: the number of consultations with the out-of-hours cooperative was the same for the intervention and control group. Also no effects were found in the secondary outcome parameters: other types of contact with their own GP, hospital admissions and place of death. Yet, in the intervention group only 24 % of the patients that died of cancer, CHF or COPD, had been identified as in need of palliative care. In addition, only half of the trained GPs actually identified patients, and coaching sessions were requested for only a part of patients. For those reasons, we performed a post-hoc analysis in which we studied the outcomes regarding those patients that had actually been identified by the trained GPs as in need of palliative care in comparison to all the other patients from the intervention and control group. The identified patients had had more contact with their own GP in the last month of life, had half the chance to have a hospitalisation in the last three months of life, had less than half the chance to die in hospital, and twice the chance of dying at home, although the latter was not statistically significant. Of the identified patients 67 % died at home. In a recent study concerning place of death of home-dwelling patients that died after a protracted terminal illness, 52.5 % of the Dutch patients died at home, which is a much lower occurrence than of our identified patients \[[@CR29]\].

The mean age of the identified patients was ten years younger than that of the other patients. This may have influenced the place of death, as younger patients are more likely to have a partner who can take care of them which may have increased their chance of dying at home. Also in an English study, the chance of dying at home or in a hospice was higher for younger patients \[[@CR30]\]. Yet, in a German study, younger patients had a higher chance to die in hospital \[[@CR31]\]. The influence of age on the outcome is therefore unclear.

The positive effects of the intervention regarding those patients that had had anticipatory palliative care is in accordance with several other RCTs. In a Canadian nurse-led study, early palliative care for patients with advanced cancer had a significant effect on parameters such as quality of life and depressed mood \[[@CR15]\]. However, they did not find an effect on the number of hospitalizations. In an American study, Temel et al. found that early palliative care resulted in an improved quality of life and mood, less aggressive interventions and prolonged survival in patients with advanced lung cancer \[[@CR14]\]. In a cluster-RCT in Canada, Zimmermann et al. found a significant improvement in quality of life at the end of life and satisfaction with care, but no significant effect on the quality of life as measured with the Facit-spiritual well being of advanced cancer patients 3 months after inclusion \[[@CR16]\]. All three studies were restricted to patients with cancer, and in all three studies patients were included via hospitals, in contrast to our study. In these studies, the intervention was hospital-based and delivered directly to the patients. In our study GPs were included as participants, not patients. We provided them with training and tools to identify and proactively plan the care for palliative patients.

Yet, only half of the trained GPs in the intervention group identified patients in need of palliative care, and the identified number per GP was only a fraction of the number of patients that died per GP during this period. These aspects indicate an identification problem with regard to the RADPAC tool and/or an inclusion threshold. Secondly, and probably related to the limited number of identified patients: our intervention addressed GPs, while it is often a medical specialist who remains the primary caregiver for patients in their final stage of life. This is related to the fact that patients still receive disease-oriented interventions. In such cases, training GPs without actively involving the medical specialists will hardly influence the identification of palliative patients or palliative care planning. Finally, although GPs are the experts in discussing end-of-life aspects with their patients, and our intervention further strengthened this expertise, the reality of daily life still is, that timely palliative care and involving the patient in anticipating a care trajectory remains difficult, particularly in non-cancer patients. Seeing as the entire disease trajectory of patients with COPD can span 15--20 years, and of patients with CHF spans 5--10 years, which is much longer than the trajectory of most patients with cancer, changing such a long-term relation will require more efforts than just a training on anticipatory palliative care. Janssen et al. described in 2011 that for several reasons, the quality of communication about end of life issues with patients with COPD needs to be improved \[[@CR22]\]. Also in our study, more patients with cancer had been included than patients with COPD or CHF. This was also one of the conclusions of a review on palliative patient-GP communication \[[@CR32]\].

Strengths and weaknesses {#Sec12}
------------------------

This is the first RCT to study the effect of training GPs in identifying patients in need of palliative care and in providing structured palliative care planning. We were able to include many GPs in a very short period of time, which confirms their interest in palliative care \[[@CR24], [@CR33]\].

Although we planned to perform an intention-to-treat analysis, the GPs that were allocated to the intervention group but did not follow the training, were lost to follow up. The characteristics of these GPs differed slightly; they were more likely to work fulltime and they had a larger patient list. Being too busy probably caused their absence. Next, only 57 % of the GPs returned the questionnaire with patient data, and therefore we could not include their deceased patients in the analyses. Thirdly, the positive effects we found regarding those patients that had been identified as in need of palliative care, were found in a post-hoc analysis, which has not been described in the study protocol. These results need to be explored further in future studies, as we don't know whether these differences are caused by the intervention or because the identified patients are a selected group. Lastly, it was not possible to prospectively register and monitor patient data in the control group, and thus of having quality of life as outcome measure.

Conclusions {#Sec13}
===========

This study shows that the design we chose was not completely compatible with an intervention that combined identification of patients in need of palliative care and anticipatory care planning. Only a portion of the eligible patients had been identified, and in this subgroup a post-hoc analysis showed positive effects of having identified patients as in need of palliative care and providing anticipatory palliative care. For that reason, the absence of differences between the entire intervention and control group does not show a failure of anticipatory palliative care; it reflects a low number of identified patients.

We have used the insights from this study to adapt our methodology and to ensure that patients are timely identified as in need of palliative care. These adaptations are currently being applied in a prospective study on proactive supportive care in patients with COPD. Patients are recruited by the attending specialist at the moment of hospitalization for an acute exacerbation COPD, palliative care is provided by a dedicated hospital palliative care team, and the primary outcome is quality of life \[[@CR34]\].

CHF

:   coronary heart failure

COPD

:   chronic obstructive pulmonary disease

GP

:   general practitioner

NECPAL

:   Neccesidades palliativas

PIG

:   Prognostic Indicator Guide

RADPAC

:   Radboud Indicators for Palliative Care Needs

RCT

:   randomised controlled trial

SPICT

:   Supportive and Palliative Care Indicators Tool

WHO

:   World Health Organisation
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